Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Expanding Efforts Help Address Disparities in Lung Cancer Care
lungcanc
SHAWL: Largest Study of Its Kind Evaluates Sexual Dysfunction in Women...
lungcanc
Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in...
lungcanc
Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?
lungcanc
Lorlatinib in ROS1-Positive NSCLC: A Review of Recent Data
lungcanc
Potential Improvement in Lung Cancer Deaths and Overall Mortality With Integration...
lungcanc
Sustained Funding Vital for Smoking-Cessation Efforts
lungcanc
Telehealth: Bridging the Digital Divide Is Still a Work In Progress
lungcanc
Smoking Cessation After Cancer Diagnosis: A Neglected Problem
lungcanc
An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in...
lungcanc
1
2
3
...
53
Page 1 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
